AI assistant
Sending…
MYRIAD GENETICS INC — Director's Dealing 2012
Mar 8, 2012
32566_dirs_2012-03-08_35916d20-4452-4b28-baab-2b7655cc95b8.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MYRIAD GENETICS INC (MYGN)
CIK: 0000899923
Period of Report: 2012-03-07
Reporting Person: King Gary A. (Exec. VP International Ops)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-03-07 | Incentive Stock Option (right to buy) | $23.98 | A | 4170 | Acquired | 2022-03-07 | Common Stock (4170) | Direct |
| 2012-03-07 | Non-Qualified Stock Option (right to buy) | $23.98 | A | 21830 | Acquired | 2022-03-07 | Common Stock (21830) | Direct |
Footnotes
F1: The combined Incentive Stock Option and Non-Qualified Stock Option grants vest 25% annually beginning on the first anniversary date of the option grant, subject to statutory ISO limitations.
More from MYRIAD GENETICS INC
Declaration of Voting Results & Voting Rights Announcements
2026
Jun 4
Regulatory Filings
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Interim / Quarterly Report
2026
May 6
Report Publication Announcement
2026
May 5
Annual Report
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Proxy Solicitation & Information Statement
2026
Apr 14
Major Shareholding Notification
2026
Apr 7
Major Shareholding Notification
2026
Mar 27